On June 10, 2026, the Federal Trade Commission finalized a consent order resolving antitrust concerns arising from Sevita Health's $835 million acquisition of BrightSpring Health Services' community living business. The order brings to a close the agency's review of a transaction that raised competitive questions in several concentrated local markets for community-based services for individuals with intellectual and developmental disabilities. For healthcare providers, investors, and acquirers, the order offers a fresh data point on how the FTC continues to approach consolidation in services markets where local choice is limited.
Under the terms of the final consent order, Sevita is required to divest 128 intermediate care facilities, along with related day-training programs, located across Indiana, Louisiana, and Texas. The designated buyer is Dungarvin Group Inc., a long-standing provider in the community living sector. The scope of the divestiture reflects the FTC's geographically granular approach to market definition in healthcare services matters and its preference for structural remedies over behavioral commitments when local competitive overlaps are identified.
Notably, the order does not stop at requiring asset transfers. Sevita must also actively assist Dungarvin in securing the licenses and certifications necessary to operate the divested facilities. This obligation underscores a recurring theme in recent FTC healthcare enforcement: the agency is increasingly attentive to whether a divestiture buyer can realistically step in and provide effective competition from day one. In sectors where state licensure, Medicaid certification, and accreditation are prerequisites to operation, asset transfer alone is rarely sufficient to preserve competition.
The finalized order signals continued FTC scrutiny of healthcare consolidation and the agency's willingness to require substantial structural remediesΓÇöincluding divestitures coupled with licensing transition obligationsΓÇöto clear acquisitions in concentrated local services markets. Parties contemplating transactions in community living, post-acute care, behavioral health, and similar service lines should anticipate close review of local market overlaps, careful vetting of any proposed divestiture buyer, and detailed commitments regarding regulatory transitions. Early engagement with antitrust counsel, thoughtful identification of viable buyers, and realistic planning for licensure transfer timelines can materially affect both deal certainty and closing timelines.
This alert provides a general overview and is not legal advice. Clients facing transactions or regulatory matters in this area should seek tailored advice from qualified counsel.